help button home button Am J Pathol ASIP 2008 Summer Academy, Molecular Methcanisms of Human Disease: Injury, Inflammation, and Tissue Repair
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Order Full text via Infotrieve
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kitamoto, T.
Right arrow Articles by Tateishi, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kitamoto, T.
Right arrow Articles by Tateishi, J.

American Journal of Pathology, Vol 141, 271-277, Copyright © 1992 by American Society for Investigative Pathology


REGULAR ARTICLES

The primary structure of the prion protein influences the distribution of abnormal prion protein in the central nervous system

T Kitamoto, K Doh-ura, T Muramoto, M Miyazono and J Tateishi
Department of Neuropathology, Kyushu University, Fukuoka, Japan.

We immunohistochemically examined tissue sections from patients with prion protein (PrP) polymorphism using hydrolytic autoclaving enhancement. Abnormal PrP accumulations could be classified into plaque formations (plaque-type) and the diffuse gray matter stainings including synaptic structures (synaptic-type). Insertional polymorphism, a point mutation in codon 102 or 117/129, and a polymorphism in codon 129 (Val129) result in plaque-type PrP accumulations. The patients with codon 102 mutation also have synaptic- type PrP accumulations. However, a point mutation in codon 200 did not show plaque-type accumulations, and only showed synaptic-type PrP accumulations. Likewise, sporadic Creutzfeldt-Jakob disease patients without any known mutations only have synaptic type accumulations. These results imply that the primary structures of PrP influence the phenotype of prion diseases, especially in abnormal PrP distributions of the central nervous system.


This article has been cited by other articles:


Home page
J. Histochem. Cytochem.Home page
P. Rezaie, C. C. Pontikis, L. Hudson, N. J. Cairns, and P. L. Lantos
Expression of Cellular Prion Protein in the Frontal and Occipital Lobe in Alzheimer's Disease, Diffuse Lewy Body Disease, and in Normal Brain: An Immunohistochemical Study
J. Histochem. Cytochem., August 1, 2005; 53(8): 929 - 940.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. K. Sandberg and P. Low
Altered Interaction and Expression of Proteins Involved in Neurosecretion in Scrapie-infected GT1-1 Cells
J. Biol. Chem., January 14, 2005; 280(2): 1264 - 1271.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
V. Lewis, S. Collins, A. F. Hill, A. Boyd, C. A. McLean, M. Smith, and C. L. Masters
Novel prion protein insert mutation associated with prolonged neurodegenerative illness
Neurology, May 27, 2003; 60(10): 1620 - 1624.
[Abstract] [Full Text] [PDF]


Home page
Ann. N. Y. Acad. Sci.Home page
E. MASLIAH
The Role of Synaptic Proteins in Alzheimer's Disease
Ann. N.Y. Acad. Sci., December 1, 2000; 924(1): 68 - 75.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
J.-J. Hauw, V. Sazdovitch, J.-L. Laplanche, K. Peoc'h, N. Kopp, J. Kemeny, N. Privat, N. Delasnerie-Laupretre, J. P. Brandel, J. P. Deslys, et al.
Neuropathologic variants of sporadic Creutzfeldt-Jakob disease and codon 129 of PrP gene
Neurology, April 25, 2000; 54(8): 1641 - 1646.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
L. A. Shinobu and M. P. Frosch
Case 28-1999- A 68-Year-Old Woman with Rapidly Progressive Dementia and a Gait Disorder
N. Engl. J. Med., September 16, 1999; 341(12): 901 - 908.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1992 by the American Society for Investigative Pathology.